Pages that link to "Q34227964"
Jump to navigation
Jump to search
The following pages link to Prion pathogenesis in the absence of Toll-like receptor signalling (Q34227964):
Displaying 41 items.
- Prion pathogenesis in the absence of NLRP3/ASC inflammasomes (Q27316552) (← links)
- NLRP3 inflammasome activation in macrophage cell lines by prion protein fibrils as the source of IL-1β and neuronal toxicity (Q30446504) (← links)
- Tickling the TLR7 to cure viral hepatitis (Q33690260) (← links)
- Subtype and regional-specific neuroinflammation in sporadic creutzfeldt-jakob disease (Q33997514) (← links)
- Protein aggregation diseases: pathogenicity and therapeutic perspectives (Q34101110) (← links)
- MicroRNA 146a (miR-146a) is over-expressed during prion disease and modulates the innate immune response and the microglial activation state (Q34170278) (← links)
- Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis (Q34312767) (← links)
- Streptococcus pneumoniae Infection aggravates experimental autoimmune encephalomyelitis via Toll-like receptor 2. (Q34975805) (← links)
- Mammalian prion biology: one century of evolving concepts (Q35639302) (← links)
- Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system (Q35742370) (← links)
- The immunology of neurodegeneration (Q35860997) (← links)
- Antiprion immunotherapy: to suppress or to stimulate? (Q35877214) (← links)
- Transcriptional Dysregulation of Upstream Signaling of IFN Pathway in Chronic HCV Type 4 Induced Liver Fibrosis. (Q36004897) (← links)
- Prions and their lethal journey to the brain (Q36389302) (← links)
- Prion diseases of humans and farm animals: epidemiology, genetics, and pathogenesis (Q36521947) (← links)
- Pathogenesis of prion diseases: current status and future outlook (Q36596483) (← links)
- Accelerated prion disease pathogenesis in Toll-like receptor 4 signaling-mutant mice (Q36949606) (← links)
- Absence of CD14 delays progression of prion diseases accompanied by increased microglial activation (Q37336725) (← links)
- Cells and prions: a license to replicate (Q37520006) (← links)
- Interferon β protects against lethal endotoxic and septic shock through SIRT1 upregulation (Q37605815) (← links)
- Toll-like receptors expression and signaling in glia cells in neuro-amyloidogenic diseases: towards future therapeutic application (Q37779740) (← links)
- Prion disease and the innate immune system (Q38076137) (← links)
- Innate immunity and neuroinflammation (Q38120744) (← links)
- The immunobiology of prion diseases (Q38159911) (← links)
- Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration (Q38345478) (← links)
- Toll-like receptor 2 deficiency shifts PrP106-126-induced microglial activation from a neurotoxic to a neuroprotective phenotype (Q38946510) (← links)
- Protective role of interferon regulatory factor 3-mediated signaling against prion infection. (Q39387817) (← links)
- Persistent retroviral infection with MoMuLV influences neuropathological signature and phenotype of prion disease (Q39407430) (← links)
- Microglia in prion diseases (Q40132256) (← links)
- Skin-derived dendritic cells acquire and degrade the scrapie agent following in vitro exposure (Q40383848) (← links)
- Toll-like receptor-mediated immune response inhibits prion propagation. (Q40790120) (← links)
- Progress and problems in the biology, diagnostics, and therapeutics of prion diseases (Q41062579) (← links)
- Protective role of MyD88-independent innate immune responses against prion infection (Q42018061) (← links)
- Comparison of inflammatory and acute-phase responses in the brain and peripheral organs of the ME7 model of prion disease (Q42709847) (← links)
- Introduction to Prion Disorders (Q57083613) (← links)
- Chapter 10 Prions (Q57083642) (← links)
- Chapter 7 A Neuropathologist's Diary (Q57083643) (← links)
- Expression of selected genes isolated from whole blood, liver and obex in lambs with experimental classical scrapie and healthy controls, showing a systemic innate immune response at the clinical end-stage (Q58748345) (← links)
- Toll-like receptor 2 confers partial neuroprotection during prion disease (Q60925110) (← links)
- Type I interferon protects neurons from prions in in vivo models (Q64284872) (← links)
- How microbiota shape microglial phenotypes and epigenetics (Q90385883) (← links)